Lorianne Masuoka

Lorianne Masuoka

Nessuna posizione attualmente
64 anni
Health Technology
Consumer Services

Profilo

Lorianne K.
Masuoka
worked as Senior Associate Director-Clinical Development at Bayer Schering Pharma AG and Berlex Laboratories, Inc. from 1994 to 2000.
From 2000 to 2003, served as Oncology Director at Chiron Corp.
Held the position of Vice President-Clinical Development at Five Prime Therapeutics, Inc. between 2003 and 2008.
Occupied the role of Chief Medical Officer & Senior Vice President at Nektar Therapeutics from 2009 to 2011.
Served as Chief Medical Officer at Cubist Pharmaceuticals LLC from 2013 to 2015, Invivo Therapeutics Holdings Corp.
from 2015 to 2017, Immedica Pharma US, Inc. from 2017 to 2019, Epygenix Therapeutics, Inc. from 2022 to 2023, and DiaMedica Therapeutics, Inc. from 2024 to 2025.
Held Independent Director roles at The Pelican, Inc. from 2019 to 2020 and Opiant Pharmaceuticals, Inc. from 2021 to 2023.
Education includes undergraduate and doctorate degrees from the University of California, Davis.

Precedenti posizioni note di Lorianne Masuoka

SocietàPosizioneFine
DIAMEDICA THERAPEUTICS INC. Direttore Tecnico/Scientifico/R&S 04/08/2025
Direttore Tecnico/Scientifico/R&S 01/12/2023
OPIANT PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 02/03/2023
PFENEX INC. Direttore/Membro del Consiglio 01/10/2020
MARINUS PHARMACEUTICALS, INC. Direttore Tecnico/Scientifico/R&S 31/10/2019
Vedi nel dettaglio l'esperienza di Lorianne Masuoka

Formazione di Lorianne Masuoka

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

56

Relazioni di 1° grado

13

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Berlex Laboratories, Inc.

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Lorianne Masuoka
40% di sconto: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA